Evolving Management of Oligometastatic Disease
نویسندگان
چکیده
منابع مشابه
Stereotactic Body Radiotherapy in the Management of Oligometastatic Disease.
BACKGROUND The treatment of oligometastatic disease has become common as imaging techniques have advanced and the management of systemic disease has improved. Use of highly targeted, hypofractionated regimens of stereotactic body radiotherapy (SBRT) is now a primary management option for patients with oligometastatic disease. METHODS The properties of SBRT are summarized and the results of re...
متن کاملEvolving Treatment of Oligometastatic Hormone-Sensitive Prostate Cancer.
Oligometastatic disease was postulated by Hellman and Weichselbaum in 1995 to be a disease state that may reflect a time point in the malignant process that may be amenable to local therapies to allow for patients to achieve a durable response or possible cure despite having advanced disease. Aggressive metastasis-directed therapy has been used in malignancies such as renal cell carcinoma, non-...
متن کاملThe role of radiation therapy in the modern management of oligometastatic disease.
Multimodal treatment approaches are indispensable for patients with advanced-stage cancer, while radiation therapy has been established as essential part of therapeutic approaches and has been introduced as a better option to face challenges, such as, local relapse or oligometastatic disease. The mere insight of the concept of oligometastases, proposed for the first time in the middle 1990s, le...
متن کاملThe Evolving Landscape of Thromboembolic Disease: Diagnostic and Management Strategies.
This issue of the Rhode Island Medical Journal focuses on the broad topic of thromboembolic disease, its many and varied clinical presentations, their incidence, symptoms, diagnostic evaluation and, most importantly, their unique management and treatment strategies. DRS. P. RILEY, A. MAAN and K.S. KORR open with an update on the current status of the Direct-Acting Oral Anticoagulants (DOACs), f...
متن کاملThe Evolving Paradigm in the Management of Intracranial Atherosclerotic Disease
Intracranial atherosclerotic disease (ICAD) is a major cause of ischemic stroke worldwide and represents a significant health problem. The pathogenesis and natural history of ICAD are poorly understood, and rigorous treatment paradigms do not exist as they do for extracranial atherosclerosis. Currently, the best treatment for ICAD remains aspirin therapy, but many patients who are placed on asp...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Immunotherapy and Precision Oncology
سال: 2020
ISSN: 2590-017X,2666-2345
DOI: 10.36401/jipo-20-x3